Dme Capital Management, LP Teva Pharmaceutical Industries LTD Transaction History
Dme Capital Management, LP
- $2.18 Trillion
- Q1 2024
A detailed history of Dme Capital Management, LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Dme Capital Management, LP holds 324,850 shares of TEVA stock, worth $5.31 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
324,850Holding current value
$5.31 Million% of portfolio
0.21%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
542Shares Held
548MCall Options Held
19.8MPut Options Held
14M-
Black Rock Inc. New York, NY43.7MShares$715 Million0.01% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.6MShares$631 Million36.28% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L334.6MShares$566 Million7.05% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.9MShares$488 Million6.74% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L328.8MShares$471 Million4.57% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...